CLINICAL AND METABOLIC STUDY OF A NEW PILL CONTAINING 20 MCG ETHINYLESTRADIOL PLUS 0.150 MG DESOGESTREL

被引：22
作者：
FIORETTI, P
FRUZZETTI, F
NAVALESI, R
RICCI, C
MICCOLI, R
CERRI, M
ORLANDI, MC
MELIS, GB
机构：
[1] UNIV PISA,DEPT OBSTET & GYNECOL,OSTETR & GINECOL CLIN,VIA ROMA 35,I-56100 PISA,ITALY
[2] UNIV PISA,DEPT METAB DIS,I-56100 PISA,ITALY
来源：
CONTRACEPTION | 1987年 / 35卷 / 03期
关键词：
D O I：
10.1016/0010-7824(87)90025-4
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：229 / 243
页数：15
相关论文
共 12 条
[1]  
BOTTIGER LE, 1980, LANCET, V1, P1097
[2]   ORAL-CONTRACEPTIVES, LIPIDS AND CARDIOVASCULAR-DISEASE [J].
FOTHERBY, K .
CONTRACEPTION, 1985, 31 (04) :367-394
[3]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[4]   SERUM-LIPID AND LIPOPROTEIN CHANGES INDUCED BY NEW ORAL-CONTRACEPTIVES CONTAINING ETHINYLESTRADIOL PLUS LEVONORGESTREL OR DESOGESTREL [J].
GASPARD, UJ ;
BURET, J ;
GILLAIN, D ;
ROMUS, MA ;
LAMBOTTE, R .
CONTRACEPTION, 1985, 31 (04) :395-408
[5]  
Harrison RF, 1984, ADV FERTILITY CONTRO, P71
[6]  
LENZI S, 1987, CLIN CHEM, V33, P55
[7]  
MEADE TW, 1977, LANCET, V2, P948
[8]   FIBRINOPEPTIDE A PLASMA-LEVELS DURING LOW-ESTROGEN ORAL-CONTRACEPTIVE TREATMENT [J].
MELIS, GB ;
FRUZZETTI, F ;
PAOLETTI, AM ;
CARMASSI, F ;
FIORETTI, P .
CONTRACEPTION, 1984, 30 (06) :575-583
[9]   ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE .1. [J].
STADEL, BV .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (11) :612-618
[10]   ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE .2. [J].
STADEL, BV .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (12) :672-677
12